Cargando…
Consensus siRNA for inhibition of HCV genotype-4 replication
BACKGROUND: HCV is circulating as a heterogeneous group of quasispecies. It has been addressed that siRNA can inhibit HCV replication in-vitro using HCV clone and/or replicon which have only one genotype. The current study was conducted to assess whether siRNA can inhibit different HCV genotypes wit...
Autores principales: | Zekri, Abdel Rahman N, Bahnassy, Abeer A, El-Din, Hanaa M Alam, Salama, Hosny M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661880/ https://www.ncbi.nlm.nih.gov/pubmed/19173711 http://dx.doi.org/10.1186/1743-422X-6-13 |
Ejemplares similares
-
New insight into HCV E1/E2 region of genotype 4a
por: Hussein, Nehal, et al.
Publicado: (2014) -
Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4
por: Zekri, Abdel Rahman N, et al.
Publicado: (2007) -
Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease
por: Salama, Hosny, et al.
Publicado: (2014) -
Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2010) -
Characterization of chronic HCV infection-induced apoptosis
por: Zekri, Abdel-Rahman N, et al.
Publicado: (2011)